Nature

Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma

The use of fluorodeoxyglucose (FDG) positron emission tomography (PET) in lymphoma has been greatly increasing over the past few years. FDG PET has been demonstrated to improve detection of occult ...
ascopubs.org

Post-treatment [18F] fluorodeoxyglucose positron emission tomography as a prognostic tool for progression-free survival in epithelial ovarian cancer

Oxaliplatin and 5-fluorouracil in heavily pretreated patients with ovarian carcinoma: A well tolerated and efficient treatment No significant financial relationships to disclose. This is an ASCO ...
ascopubs.org

Positron Emission Tomography–Positive Post-Chemotherapy Seminoma Masses: Time to Reevaluate the Role of Radiotherapy?

Positron Emission Tomography–Positive Post-Chemotherapy Seminoma Masses: Time to Reevaluate the Role of Radiotherapy? The following represents disclosure information provided by authors of this ...
Nature

Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma

After receiving approval from the Duke University Institutional Review Board, records from consecutive patients who underwent either auto-SCT for relapsed or refractory HD or aggressive NHL (including ...
PharmiWeb

Demand for Positron Emission Tomography (PET) Scanners Set for Stupendous Growth in and Post 2020, Buoyed by the Global COVID-19 Pandemic

The report “Positron Emission Tomography (PET) Scanners Market: Global Industry Analysis and Opportunity Assessment, 2016–2026” offers a 10-year forecast for the global Positron Emission Tomography ...